174G>C interleukin-6 gene polymorphism in Tunisian patients with coronary artery disease

A state of low-grade inflammation accompanies the pathogenesis of atherosclerotic events. Interleukin-6 (IL-6) is a pleotropic pro-inflammatory cytokine that modulates the development of acute coronary syndromes (ACSs), partly by destabilizing coronary atherosclerotic plaques. We have examined the c...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Annals of Saudi medicine Ročník 31; číslo 1; s. 40 - 44
Hlavní autori: Ghazouani, Lakhdar, Abboud, Nesrine, Khalifa, Sonia Ben Hadj, Added, Faouzi, Khalfallah, Ali Ben, Nsiri, Brahim, Mediouni, Mounira, Mahjoub, Touhami
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Saudi Arabia KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTRE 01.01.2011
Medknow Publications
King Faisal Specialist Hospital and Research Centre
Predmet:
ISSN:0256-4947, 0975-4466, 0975-4466
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:A state of low-grade inflammation accompanies the pathogenesis of atherosclerotic events. Interleukin-6 (IL-6) is a pleotropic pro-inflammatory cytokine that modulates the development of acute coronary syndromes (ACSs), partly by destabilizing coronary atherosclerotic plaques. We have examined the contribution of the -174G>C IL-6 promoter variant on the risk of coronary artery disease (CAD) among Tunisians. Study subjects included 418 CAD patients and 406 age- and sex-matched controls. IL-6 genotyping was done by PCR-restriction fragment length polymorphism. The frequency of the -174C allele (mutant) was lower in Tunisians than in Europeans, and the distribution of -174 G>C genotypes was similar between CAD patients and control subjects. Moreover, compared to GG genotype carriers, -174C allele carriage did not increase the CAD relative risk (odds ratio and 95% confidence interval=1.09 and 0.80-1.49), which remained nonsignificant after adjusting for traditional risk factors for CAD (age, smoking, hypertension, diabetes and obesity). The -174G>C IL-6 promoter variant is not associated with an increased risk of CAD among Tunisians.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0256-4947
0975-4466
0975-4466
DOI:10.4103/0256-4947.75777